SEC
|
SASSINE ANDY
|
Chief Financial Officer
|
|
-1.2K
|
$16.56
|
-$20.50K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-12K
|
$20.76
|
-$249.12K
|
|
SEC
|
SASSINE ANDY
|
Chief Financial Officer
|
|
-50K
|
$32.03
|
-$1.60M
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-114
|
$45.00
|
-$5.13K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-26K
|
$40.01
|
-$1.04M
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-17K
|
$35.02
|
-$610.57K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-8.6K
|
$35.01
|
-$299.86K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-5K
|
$25.61
|
-$128.05K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-5K
|
$31.45
|
-$157.25K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-5K
|
$34.91
|
-$174.55K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-25K
|
$35.01
|
-$875.25K
|
|
SEC
|
Kummerfeld Keith C
|
See Remarks
|
|
-7K
|
$35.00
|
-$243.88K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-5K
|
$28.75
|
-$143.75K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-5K
|
$27.16
|
-$135.80K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-25K
|
$30.08
|
-$752.00K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-5K
|
$25.93
|
-$129.65K
|
|
SEC
|
Kummerfeld Keith C
|
See Remarks
|
|
-7K
|
$28.18
|
-$196.36K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-5K
|
$25.38
|
-$126.90K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-5K
|
$16.07
|
-$80.35K
|
|
SEC
|
Marquet Magda
|
N/A
|
|
+2.2K
|
$18.00
|
+$40.00K
|
|
SEC
|
Payne Joseph E
|
President and CEO
|
|
+5K
|
$16.51
|
+$82.55K
|
|
SEC
|
SASSINE ANDY
|
Chief Financial Officer
|
|
+2.1K
|
$18.42
|
+$39.35K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-8.1K
|
$40.00
|
-$324.00K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-3.6K
|
$40.00
|
-$145.32K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-6.4K
|
$40.00
|
-$254.68K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-10K
|
$44.41
|
-$444.10K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-10K
|
$44.36
|
-$443.60K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-10K
|
$55.86
|
-$558.60K
|
|
SEC
|
Ultragenyx Pharmaceutical Inc.
|
N/A
|
|
-800K
|
$54.54
|
-$43.63M
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-10K
|
$40.07
|
-$400.70K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-10K
|
$42.95
|
-$429.50K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-10K
|
$54.23
|
-$542.30K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-10K
|
$75.31
|
-$753.10K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-10K
|
$46.40
|
-$464.00K
|
|
SEC
|
Ultragenyx Pharmaceutical Inc.
|
N/A
|
|
-800K
|
$100.81
|
-$80.65M
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-10K
|
$96.19
|
-$961.90K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-10K
|
$55.28
|
-$552.80K
|
|
SEC
|
Chivukula Pad
|
Chief Scientific Officer & COO
|
|
-10K
|
$42.83
|
-$428.30K
|
|
SEC
|
Kummerfeld Keith C
|
See Remarks
|
|
+450
|
$33.33
|
+$15.00K
|
|
SEC
|
Payne Joseph E
|
President and CEO
|
|
+1K
|
$31.69
|
+$31.69K
|
|
SEC
|
SASSINE ANDY
|
Chief Financial Officer
|
|
+5K
|
$29.74
|
+$148.70K
|
|
SEC
|
Ultragenyx Pharmaceutical Inc.
|
N/A
|
|
+600K
|
$16.00
|
+$9.60M
|
|
SEC
|
SASSINE ANDY
|
Chief Financial Officer
|
|
+5.6K
|
$9.73
|
+$54.96K
|
|
SEC
|
SASSINE ANDY
|
Chief Financial Officer
|
|
+10K
|
$10.00
|
+$100.00K
|
|
SEC
|
Marquet Magda
|
N/A
|
|
+2.3K
|
$10.58
|
+$24.33K
|
|
SEC
|
Kummerfeld Keith C
|
See Remarks
|
|
+500
|
$10.69
|
+$5.35K
|
|
SEC
|
Payne Joseph E
|
President and CEO
|
|
+5K
|
$11.22
|
+$56.10K
|
|
SEC
|
SASSINE ANDY
|
Chief Financial Officer
|
|
+10K
|
$10.90
|
+$109.00K
|
|
SEC
|
FARRELL PETER C
|
N/A
|
|
+9.1K
|
$10.94
|
+$99.70K
|
|
SEC
|
Jones Brian D
|
CFO and Treasurer
|
|
+1K
|
$11.00
|
+$11.00K
|
|
SEC
|
KAHANE WILLIAM M
|
President and CEO
|
|
+10K
|
$11.10
|
+$111.00K
|
|
SEC
|
SCHORSCH NICHOLAS S
|
N/A
|
|
+10K
|
$11.10
|
+$111.00K
|
|